{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:35:25Z","timestamp":1788554125319,"version":"build-2803163510"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Estimation of serum concentrations of antiseizure medications (ASMs) based on dried capillary blood is an alternative method for therapeutic drug monitoring of epilepsy. The aim of this study was to validate the conversion factors for lacosamide (LCM), lamotrigine (LTG), and levetiracetam (LEV), which were determined in an independent patient sample in a previous study, and identify the most accurate conversion method (simple ratio and regression).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Venous and capillary blood samples were collected from adult inpatients with epilepsy treated with LCM (n = 25), LTG (n = 27), and\/or LEV (n = 29) before the morning dose (T1) and approximately 2 hours after (T2). Capillary blood was collected using volumetric absorptive microsampling, and the ASM concentrations were measured using a validated liquid chromatography\u2013mass spectrometry method for dried blood samples. Serum concentrations were estimated using conversion factors and compared with those measured using routine laboratory methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      For all 3 ASMs, the simple ratio approach performed better than the regression approach. Intraclass correlation coefficients revealed a high agreement between the estimated and measured serum concentrations (LCM T1: 0.93, T2: 0.90; LTG T1: 0.91, T2: 0.91; and LEV T1: 0.97, T2: 0.94). The criteria of the European Medicines Agency for cross-validation were fulfilled for LCM (T1: 72%; T2: 75%) and LEV (T1: 86%; T2: 75%), whereas for LTG, this was only true for capillary blood concentrations \u226411\n                      <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                      g\/mL [42.9\n                      <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                      mol\/L; T1: 72% (vs. 63% for total range), T2: 67% (vs. 62%)].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Estimating serum concentrations using capillary blood concentrations is feasible and accurate for LCM and LEV over a wide concentration range, as found in clinical practice. The applicability of this mehod for LTG is limited by its greater variability at higher concentrations; however, acceptable results were achieved for the large proportion of patients with low and medium LTG concentrations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001056","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T19:00:09Z","timestamp":1666897209000},"page":"546-553","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Validation of Conversion Factors for Therapeutic Drug Monitoring of Lacosamide, Lamotrigine, and Levetiracetam in Dried Capillary Blood"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8158-7442","authenticated-orcid":false,"given":"Anne","family":"Hagemann","sequence":"first","affiliation":[{"name":"Society for Epilepsy Research, Bielefeld, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Klimpel","sequence":"additional","affiliation":[{"name":"MVZ Labor Krone GbR, Bad Salzuflen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Schmitter","sequence":"additional","affiliation":[{"name":"MVZ Labor Krone GbR, Bad Salzuflen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Bien","sequence":"additional","affiliation":[{"name":"Society for Epilepsy Research, Bielefeld, Germany;"},{"name":"Bielefeld University, Medical School, Department of Epileptology (Krankenhaus Mara), Bielefeld, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertin","family":"Dufaux","sequence":"additional","affiliation":[{"name":"MVZ Labor Krone GbR, Bad Salzuflen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor W","family":"May","sequence":"additional","affiliation":[{"name":"Protestant Hospital of Bethel Foundation, University Medical School OWL, Bielefeld University, Campus Bielefeld-Bethel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brandt","sequence":"additional","affiliation":[{"name":"Society for Epilepsy Research, Bielefeld, Germany;"},{"name":"Bielefeld University, Medical School, Department of Epileptology (Krankenhaus Mara), Bielefeld, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1515\/jlm.2011.022","article-title":"Therapeutic drug monitoring of newer antiepileptic drugs\/Therapeutic drug monitoring bei neueren Antiepileptika","volume":"35","author":"Brandt","year":"2011","journal-title":"LaboratoriumsMedizin"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/FTD.0000000000000890","article-title":"Therapeutic drug monitoring of lamotrigine, lacosamide, and levetiracetam in dried capillary blood-determination of conversion factors for serum-based reference ranges","volume":"43","author":"Klimpel","year":"2021","journal-title":"Ther Drug Monit"},{"key":"R3-20250603","first-page":"431","article-title":"Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II","volume":"22","author":"Passing","year":"1984","journal-title":"J Clin Chem Clin Biochem."},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official international association for therapeutic drug monitoring and clinical toxicology guideline: development and validation of dried blood spot-based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R5-20250603","first-page":"185","article-title":"Appendix B to the GTFCh guidelines for quality assurance in forensic-toxicologic analysis: requirements for the validation of analytical methods [Anhang B zur Richtlinie der GTFCh zur Qualit\u00e4tssicherung bei forensisch-toxikologischen Untersuchungen: anforderungen an die Validierung von Analysenmethoden]","volume":"76","author":"Peters","year":"2009","journal-title":"Toxichem Krimtech"},{"key":"R6-20250603","article-title":"der Bundes\u00e4rztekammer zur Qualit\u00e4tssicherung laboratoriumsmedizinischer Untersuchungen [in German]","volume":"116","author":"Richtlinie","year":"2019","journal-title":"Dtsch Arztebl"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"327","author":"Bland","year":"1986","journal-title":"The Lancet"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/uog.122","article-title":"Applying the right statistics: analyses of measurement studies","volume":"22","author":"Bland","year":"2003","journal-title":"Ultrasound Obstet Gynecol."},{"key":"R10-20250603","first-page":"1","article-title":"Design based on intra-class correlation coefficients","volume":"1","author":"Doros","year":"2010","journal-title":"Am J Biostatistics"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/FTD.0000000000000605","article-title":"Dried blood spot self-sampling by guardians of children with epilepsy is feasible: comparison with plasma for multiple antiepileptic drugs","volume":"41","author":"Linder","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.clinbiochem.2013.10.011","article-title":"Clinical evaluation of a dried blood spot method for determination of mycophenolic acid in renal transplant patients","volume":"46","author":"Arpini","year":"2013","journal-title":"Clin Biochem."},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/jcph.728","article-title":"The use of dried blood spots for pharmacokinetic monitoring of vemurafenib treatment in melanoma patients","volume":"56","author":"Nijenhuis","year":"2016","journal-title":"J Clin Pharmacol."},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clinbiochem.2016.12.008","article-title":"Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: a step towards home sampling","volume":"50","author":"Linder","year":"2017","journal-title":"Clin Biochem."},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/FTD.0000000000000652","article-title":"Volumetric absorptive microsampling: a new sampling tool for therapeutic drug monitoring of antiepileptic drugs","volume":"41","author":"D'Urso","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/01.WNL.0000138424.33979.0C","article-title":"Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy","volume":"63","author":"Hirsch","year":"2004","journal-title":"Neurology"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bcpt.13269","article-title":"Development and clinical applications of the dried blood spot method for therapeutic drug monitoring of anti-epileptic drugs","volume":"125","author":"Min","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/21548331.2017.1296318","article-title":"Determination of serum carbamazepine concentration using dried blood spot specimens for resource-limited settings","volume":"45","author":"Das","year":"2017","journal-title":"Hosp Pract."},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11095-021-03036-6","article-title":"Dried blood spot technique applied in therapeutic drug monitoring of anticancer drugs: a review on conversion methods to correlate plasma and dried blood spot concentrations","volume":"38","author":"Iacuzzi","year":"2021","journal-title":"Pharm Res."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T13:12:55Z","timestamp":1748956375000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001056","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"assertion":[{"value":"2022-07-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}